9/16/2022 7:03:31 AM
Kite Says EMA Committee For Medicinal Products For Human Use Issues Positive Opinion For Yescarta
9/16/2022 6:52:51 AM
Gilead Sciences: CHMP Adopts Positive Opinion To Extend Indication Of Veklury For Pediatric Patients With COVID-19
8/22/2022 1:03:36 AM
Gilead Sciences Says European Commission Grants Marketing Authorization For Sunlenca
8/17/2022 12:05:22 PM
Gilead Sciences Collaborates With Morehouse School Of Medicine, Xavier University Of Louisiana College Of Pharmacy
8/15/2022 7:47:20 PM
Gilead To Acquire Remaining Worldwide Rights Of Trodelvy
8/15/2022 8:36:39 AM
Gilead :Trodelvy Improves Overall Survival In Pre-Treated HR+/HER2-
Metastatic Breast Cancer Patients In Phase 3 Study
8/4/2022 8:03:53 AM
Gilead To Buy MiroBio For About $405 Mln Cash
8/2/2022 5:18:47 PM
Gilead Sciences Inc. (GILD) Has Raised Its FY22 Revenue Estimate To $24.5 - $25.0 Bln From $23.8 - $24.3 Bln
8/2/2022 5:17:59 PM
Gilead Sciences Inc. (GILD) Has Raised Its FY22 EPS Estimate To 6.30 - 6.75 From 6.20 - 6.70
8/2/2022 5:14:49 PM
Gilead Sciences Inc. (GILD) Declares Quarterly Dividend of $ 0.73, Record Date 9/15/2022
8/2/2022 5:08:25 PM
Gilead Sciences Q2 EPS $0.91 Vs. $1.21 Year Ago